PRELUDE CAPITAL MANAGEMENT, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q4 2021$3,338,000
+15.4%
75,7000.0%0.09%
+16.2%
Q3 2021$2,892,000
+416.4%
75,700
+382.2%
0.07%
+428.6%
Q1 2021$560,000
+0.7%
15,700
+4.0%
0.01%0.0%
Q4 2020$556,000
-2.8%
15,100
-0.7%
0.01%
-50.0%
Q3 2020$572,000
+1261.9%
15,200
+1358.7%
0.03%
+600.0%
Q3 2017$42,000
-96.0%
1,042
-95.8%
0.00%
-96.0%
Q2 2017$1,062,000
-41.2%
24,618
-42.5%
0.10%
-41.6%
Q1 2017$1,805,00042,8170.17%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2017
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders